A carregar...

Acquired Resistance to EGFR Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma

PURPOSE: Somatic mutations in the tyrosine kinase domain of EGFR are associated with sensitivity of lung adenocarcinomas to the EGFR tyrosine kinase inhibitors (TKIs), gefitinib and erlotinib. Acquired drug resistance is frequently associated with a secondary somatic mutation that leads to substitut...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bean, James, Riely, Gregory J., Balak, Marissa, Marks, Jenifer L., Ladanyi, Marc, Miller, Vincent A., Pao, William
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2596620/
https://ncbi.nlm.nih.gov/pubmed/19010870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!